How is Teclistamab CQYV dosed?
The recommended dose of Teclistamab CQYV is 1650 mg administered as a subcutaneous injection once every 3 weeks. Dosage adjustments may be necessary based on the individual's response to treatment, medical history, and other medications being taken.
What is the dosage form of Teclistamab CQYV?
The dosage form of Teclistamab CQYV is a solution.
How is Teclistamab CQYV administered?
Teclistamab CQYV is administered via subcutaneous injection. It is used to treat relapsed or refractory multiple myeloma in patients who have received at least 4 previous treatments, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
What are common precautions when taking Teclistamab CQYV?
When taking Teclistamab CQYV, it is important to:
- Inform your healthcare professional about any other medicines you are taking to avoid potential drug interactions.
- Be aware of potential side effects such as skin reactions at the injection site, constipation, difficulty in moving, joint pain, and muscle or bone pain.
- Report any unusual or severe side effects to your healthcare professional immediately.
- Inform your doctor if you have any allergies or other types of allergies.
- Note that the safety and efficacy of this medicine have not been established in pediatric patients.
- Follow the Tecvayli闁 REMS (Risk Evaluation and Mitigation Strategy) Program, a restricted distribution program for this medicine. Remember to follow your doctor's instructions carefully and seek medical advice if you have any concerns or questions.